(Q47926584)

6 February 2018

title

New Approach and Practical Modelling of Bead Milling Process for the Manufacturing of Nanocrystalline Suspensions (English)

1 reference

6 February 2018

author name string

Mostafa Nakach

series ordinal

1

1 reference

6 February 2018

Jean-René Authelin

series ordinal

2

1 reference

6 February 2018

Christophe Agut

series ordinal

3

1 reference

6 February 2018

language of work or name

English

0 references

publication date

13 March 2017

1 reference

6 February 2018

Journal of Pharmaceutical Sciences

published in

1 reference

6 February 2018

volume

106

1 reference

6 February 2018

issue

7

1 reference

6 February 2018

page(s)

1889-1904

1 reference

6 February 2018

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Nanosizing: a formulation approach for poorly-water-soluble compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Engineering of nano-crystalline drug suspensions: employing a physico-chemistry based stabilizer selection methodology or approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Downscaling drug nanosuspension production: processing aspects and physicochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

Nanoparticle Production with Stirred-Media Mills: Opportunities and Limits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

An analysis of variance test for normality (complete samples)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.02.036

10.1016/J.XPHS.2017.02.036

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018